1
|
Ma J, Ji C, Sun Y, Liu D, Pan K, Wei Y. Wogonin ameliorates the proliferation, inflammatory response, and pyroptosis in keratinocytes via NOD-like receptor family pyrin domain containing 3/Caspase-1/Gasdermin-D pathway. Immun Inflamm Dis 2024; 12:e1303. [PMID: 38967379 PMCID: PMC11225086 DOI: 10.1002/iid3.1303] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/05/2024] [Revised: 03/19/2024] [Accepted: 05/17/2024] [Indexed: 07/06/2024] Open
Abstract
BACKGROUND Psoriasis refers to a highly prevalent and immunologically mediated dermatosis with considerable deterioration in life quality. Wogonin, a sort of flavonoid, has been mentioned to elicit protective activities in skin diseases. However, whether Wogonin is implicated in the treatment of psoriasis and its specific mechanisms are not fully understood. AIM The present work attempted to elaborate the role of Wogonin during the process of psoriasis and to concentrate on the associated action mechanism. METHODS Cell counting kit-8 (CCK-8) method was initially applied to assay the viability of human keratinocyte HaCaT cells treated by varying concentrations of Wogonin. To mimic psoriasis in vitro, HaCaT cells were exposed to M5 cytokines. CCK-8 and 5-Ethynyl-2'-deoxyuridine assays were adopted for the measurement of cell proliferation. Inflammatory levels were examined with enzyme-linked immunosorbent assay. Immunofluorescence staining tested nucleotide-binding oligomerization domain (NOD)-like receptor family pyrin domain containing 3 (NLRP3) and Caspase-1 expressions. Western blot examined the protein expressions of proliferation-, inflammation-, pyroptosis-associated factors, and NLRP3. RESULTS Wogonin treatment antagonized the proliferation, inflammatory response, and NLRP3/caspase-1/Gasdermin-D (GSDMD)-mediated pyroptosis in M5-challenged HaCaT cells. Besides, NLRP3 elevation partially abrogated the effects of Wogonin on M5-induced proliferation, inflammatory response, and NLRP3/caspase-1/GSDMD-mediated pyroptosis in HaCaT cells. CONCLUSION In a word, Wogonin might exert anti-proliferation, anti-inflammatory and anti-pyroptosis activities in M5-induced cell model of psoriasis and the blockade of NLRP3/Caspase-1/GSDMD pathway might be recognized as a potential mechanism underlying the protective mechanism of Wogonin in psoriasis, suggesting Wogonin as a prospective anti-psoriasis drug.
Collapse
Affiliation(s)
- Jun Ma
- First College of Clinical MedicineNanjing University of Chinese MedicineNanjingChina
- Department of DermatologyThe Affiliated Zhangjiagang Hospital of Soochow UniversitySuzhouChina
| | - Chen Ji
- Department of DermatologyZhangjiagang TCM Hospital Affiliated to Nanjing University of Chinese MedicineSuzhouChina
| | - Yanhong Sun
- Department of DermatologyThe Affiliated Zhangjiagang Hospital of Soochow UniversitySuzhouChina
| | - Danqing Liu
- Department of DermatologyThe Affiliated Zhangjiagang Hospital of Soochow UniversitySuzhouChina
| | - Kai Pan
- Department of DermatologyThe Affiliated Zhangjiagang Hospital of Soochow UniversitySuzhouChina
| | - Yuegang Wei
- First College of Clinical MedicineNanjing University of Chinese MedicineNanjingChina
| |
Collapse
|
2
|
AlOrbani AM, El-Komy MHM, Mourad A, Amer MA. Psoriasis knowledge gaps and misconceptions in the Middle East and North Africa (MENA) regions: patients' survey-based study. Int J Dermatol 2024. [PMID: 38825728 DOI: 10.1111/ijd.17255] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/19/2024] [Revised: 04/14/2024] [Accepted: 04/27/2024] [Indexed: 06/04/2024]
Abstract
BACKGROUND Misconceptions among psoriatic patients often lead to a negative impact on disease outcomes. OBJECTIVES Our main target was knowledge assessment among a sample of psoriatic patients in the Middle East and North Africa (MENA) region where data are scarce. METHODS The present study is a cross-sectional descriptive survey. It consists of an online questionnaire comprising 19 questions designed to assess psoriasis knowledge and five demographic questions. The questionnaire link was posted on the official Facebook page of the Kasr Al Ainy Psoriasis Unit (KAPU). RESULTS The questionnaire was taken by 527 participants, but only 396 responses were complete and adequate for analysis. The mean psoriasis knowledge score was higher in females (P = 0.005) and participants with advanced education degrees (P < 0.001). Patients reporting regular follow-ups with dermatologists were more likely to acknowledge joint involvement (P = 0.044) but also incorrectly assume biologics are a final cure (P = 0.038). In addition, they were more likely to assume psoriasis affects pregnancy (P = 0.013). Patients with a family history of psoriasis showed a better mean knowledge score than those without (P = 0.01). Only 54.55% of participants reported knowledge of possible disease exacerbation by drugs. A minority (26.77%) of our patients responded that a diet change could not permanently cure psoriasis. CONCLUSION This study reports knowledge gaps in a cohort of Arabic-speaking psoriasis patients, especially regarding areas of extracutaneous involvement, the hereditary nature of the disease, and the effect of psoriasis on pregnancy and fertility. Most participants were unaware that biological therapy and a change in diet do not offer a permanent cure. Dermatologists in our region must reach out to their patients and correct the various misconceptions reported in this study.
Collapse
Affiliation(s)
- Aya M AlOrbani
- Kasr Al Ainy Psoriasis Unit (KAPU), Dermatology Department, Faculty of Medicine, Cairo University, Cairo, Egypt
| | - Mohamed H M El-Komy
- Kasr Al Ainy Psoriasis Unit (KAPU), Dermatology Department, Faculty of Medicine, Cairo University, Cairo, Egypt
| | - Ahmed Mourad
- Kasr Al Ainy Psoriasis Unit (KAPU), Dermatology Department, Faculty of Medicine, Cairo University, Cairo, Egypt
| | - Marwa Ahmed Amer
- Kasr Al Ainy Psoriasis Unit (KAPU), Dermatology Department, Faculty of Medicine, Cairo University, Cairo, Egypt
| |
Collapse
|
3
|
Yue C, Feng J, Gao A. A network pharmacology and molecular docking investigation on the mechanisms of Shanyaotianhua decoction (STT) as a therapy for psoriasis. Medicine (Baltimore) 2023; 102:e34859. [PMID: 37653756 PMCID: PMC10470816 DOI: 10.1097/md.0000000000034859] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/14/2023] [Revised: 07/18/2023] [Accepted: 07/31/2023] [Indexed: 09/02/2023] Open
Abstract
Psoriasis is an immune-mediated inflammatory skin disease with a complex etiology involving environmental and genetic factors. Psoriasis patients often require long-term treatment. Shanyaotianua decoction (STT), a typical traditional Chinese medicine prescription, positively affects psoriasis, although its molecular targets remain unknown. To elucidate its molecular mechanisms, a combination of network pharmacology, bioinformatics analysis, and drug similarity comparisons were employed. Participants were separated into 3 groups: non-lesional (NL), lesions after medication (LM), and psoriasis lesion groups (LS). Based on the Gene Ontology/kyoto encyclopedia of genes and genomes enrichment analyses, the key targets were mainly enriched for biological processes (immuno-inflammatory responses, leukocyte differentiation, lipid metabolic disorders, and viral infection) with the relevant pathways (Janus kinase/signal transducers and activators of transcription and adipocytokine signaling and T-helper 17 cell differentiation), thus identifying the possible action mechanism of STT against psoriasis. Target prediction for 18 STT compounds that matched the screening criteria was performed. Then, the STT compounds were intersected with the differentially expressed genes of the psoriatic process, and 5 proteins were potential targets for STT. Based on the open-source toolkit RDKit and DrugBank database, and through molecular docking and drug similarity comparisons, spinasterol, diosgenin, and 24-Methylcholest-5-enyl-3belta-O-glucopyranoside_qt may be potential drugs for psoriasis.
Collapse
Affiliation(s)
- Chen Yue
- Institute of Dermatology, Guangzhou Medical University, Guangzhou, Guangdong, China
| | - Jiahao Feng
- The Seventh Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China
| | - Aili Gao
- Institute of Dermatology, Guangzhou Medical University, Guangzhou, Guangdong, China
| |
Collapse
|
4
|
Kayıran MA, Karadağ AS, Topal İO, Emre S, Adışen E, Kılıç S, Keskin N, Polat AK, Cemil BÇ, Polat M, Yılmaz O, Ayvaz H, Demir FT, Solak SS, Uçmak D, Aytekin S, Gürel MS, Ekinci AP, Bölük KN, Şendur N, Akbulut TÖ, Öztürk G, Erbas A, Alpsoy E. Patient Use of Complementary and Alternative Medicine for Psoriasis Vulgaris and Factors Believed to Trigger the Disease: a Multicenter Cross-Sectional Study With 1621 Patients. Dermatol Pract Concept 2022; 12:e2022190. [PMID: 36534567 PMCID: PMC9681383 DOI: 10.5826/dpc.1204a190] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 03/01/2022] [Indexed: 12/11/2023] Open
Abstract
INTRODUCTION Due to the chronic recurrent nature of psoriasis vulgaris (PV) and lack of definitive treatment for the disease, patients often resort to alternative treatments. Physicians seem to have low awareness of this issue. OBJECTIVES To elicit the perceptions of 1,621 PV patients on complementary and alternative medicine (CAM) and examine factors reported to worsen PV. METHODS The patients sociodemographic characteristics, Psoriasis Area Severity Index (PASI), Dermatology Life Quality Index (DLQI), disease duration, and severity were recorded, and the patients CAM use was questioned in detail. The patients were also asked about factors that worsened PV and their experiences with a gluten-free diet. RESULTS Of the patients, 56.51% had used CAM. The mean age, illness duration, PASI scores and DLQI of those using CAM were significantly higher. CAM use was significantly higher in those with facial, genital involvement, and arthralgia/arthritis. The patients mostly referred to CAM when PV became severe (46.4%). Of the CAM users, 45.52% used herbal topicals. The physicians of 67.03% did not inquire whether they used CAM. Of the participants, 37.73% considered that stress worsened their disease. Gluten-free diet did not affect PV symptoms in 52.22%. CONCLUSIONS Patients CAM use is often overlooked by dermatologists. Our results showed that more than half the patients used CAM and did not share this information with their physicians. Therefore, the awareness of physicians should be increased and patients should be asked about the use of CAM and directed to the appropriate medical treatment options by physicians.
Collapse
Affiliation(s)
- Melek Aslan Kayıran
- İstanbul Medeniyet University, Göztepe Prof Dr Süleyman Yalçın City Hospital, Department of Dermatological and Venereal Diseases, İstanbul, Turkey
| | - Ayşe Serap Karadağ
- Ataşehir Memorial Hospital, Department of Dermatological and Venereal Diseases, İstanbul, Turkey
| | - İlteriş Oğuz Topal
- Health Sciences University, Prof. Dr. Cemil Taşçıoğlu Hospital, Department of Dermatological and Venereal Diseases, İstanbul, Turkey
| | - Selma Emre
- Yıldırım Beyazıt University, Faculty of Medicine, Department of Dermatological and Venereal Diseases, Ankara, Turkey
| | - Esra Adışen
- Gazi University, Faculty of Medicine, Department of Dermatological and Venereal Diseases, Ankara, Turkey
| | - Sevilay Kılıç
- Çanakkale 18 Mart University, Faculty of Medicine, Department of Dermatological and Venereal Diseases, Çanakkale, Turkey
| | - Nuray Keskin
- Gazi University, Faculty of Medicine, Department of Dermatological and Venereal Diseases, Ankara, Turkey
| | - Asude Kara Polat
- Health Sciences University, İstanbul Training and Research Hospital, Department of Dermatological and Venereal Diseases, İstanbul, Turkey
| | - Bengü Çevirgen Cemil
- Health Sciences University, Dışkapı Yıldırım Beyazıt Training and Research Hospital, Department of Dermatological and Venereal Diseases, Ankara, Turkey
| | - Mualla Polat
- Bolu Abant İzzet Baysal University, Faculty of Medicine, Department of Dermatological and Venereal Diseases, Bolu, Turkey
| | - Oğuz Yılmaz
- Akdeniz University, Faculty of Medicine, Department of Dermatological and Venereal Diseases, Antalya, Turkey
| | - Hilal Ayvaz
- Süleyman Demirel University, Faculty of Medicine, Department of Dermatological and Venereal Diseases, Isparta, Turkey
| | - Filiz Topaloğlu Demir
- Medipol University, Faculty of Medicine, Department of Dermatological and Venereal Diseases, İstanbul, Turkey
| | - Sezgi Sarıkaya Solak
- Trakya University, Faculty of Medicine, Department of Dermatological and Venereal Diseases, Edirne, Turkey
| | - Derya Uçmak
- Dicle University, Faculty of Medicine, Department of Dermatological and Venereal Diseases, Diyarbakır, Turkey
| | - Sema Aytekin
- Health Sciences University, Haydarpaşa Training and Research Hospital Faculty of Medicine, Department of Dermatological and Venereal Diseases, İstanbul, Turkey
| | - Mehmet Salih Gürel
- İstanbul Medeniyet University, Göztepe Prof Dr Süleyman Yalçın City Hospital, Department of Dermatological and Venereal Diseases, İstanbul, Turkey
| | - Algün Polat Ekinci
- İstanbul University, İstanbul Faculty of Medicine, Department of Dermatological and Venereal Diseases, İstanbul, Turkey
| | - Kübra Nursel Bölük
- İstanbul University, İstanbul Faculty of Medicine, Department of Dermatological and Venereal Diseases, İstanbul, Turkey
| | - Neslihan Şendur
- Adnan Menderes University, Faculty of Medicine, Department of Dermatological and Venereal Diseases, Aydın, Turkey
| | - Tuğba Özkök Akbulut
- Health Sciences University, Haseki Training and Research Hospital, Department of Dermatological and Venereal Diseases, İstanbul, Turkey
| | - Günseli Öztürk
- Ege University, Faculty of Medicine, Department of Dermatological and Venereal Diseases, İzmir, Turkey
| | - Ayda Erbas
- Ege University, Faculty of Medicine, Department of Dermatological and Venereal Diseases, İzmir, Turkey
| | - Erkan Alpsoy
- Akdeniz University, Faculty of Medicine, Department of Dermatological and Venereal Diseases, Antalya, Turkey
| |
Collapse
|
6
|
Zhang J, Yu Q, Peng L, Qin Y, Jing M, Huang D, Guo J, Xiao M, Chen M. Benefits and Safety of Chinese Herbal Medicine in Treating Psoriasis: An Overview of Systematic Reviews. Front Pharmacol 2021; 12:680172. [PMID: 34276371 PMCID: PMC8281221 DOI: 10.3389/fphar.2021.680172] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/13/2021] [Accepted: 06/09/2021] [Indexed: 12/12/2022] Open
Abstract
Background: In recent years, systematic reviews/meta-analyses (SRs/MAs) of Chinese herbal medicine (CHM) for psoriasis have continuously emerged. Their methods and evidence quality, however, are yet to be evaluated, and whether their conclusions can provide clinicians with reliable evidence is still debatable. Objectives: This overview aims to evaluate the methodological quality, risk of bias, and reporting quality of relevant SRs/MAs, as well as the current evidence of CHM for treating psoriasis. Methods: We searched nine electronic databases from their respective time of establishment to January 20, 2021, as well as the reference lists of the included SRs/MAs, protocol registries, and gray literature. Two reviewers independently used the following: A Measurement Tool to Assess Systematic Reviews (AMSTAR) 2, Risk of Bias in Systematic Reviews (ROBIS), the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA), and Grades of Recommendations, Assessment, Development and Evaluation (GRADE) to evaluate the methodological quality, risk of bias, reporting quality, and evidence quality of the included SRs/MAs. Results: This review included 14 SRs/MAs involving 45 outcomes, of which 12 (85.71%) SRs/MAs had a very low quality evaluated by AMSTAR 2 and 7 (50.00%) SRs/MAs had a high risk of bias assessed by ROBIS. The protocol and registration and funding statements were the major reporting flaws according to the PRISMA checklist. The evaluation with the GRADE system demonstrated no outcome of high-quality evidence, and inconsistent efficacy evaluations were found in this overview. Only 15 (33.33%) outcomes were moderate-quality evidence, supporting the claim that CHM plus Western medicine (WM) was superior to WM. Generally low quality of evidence showed no difference in the incidence of adverse events between the combined therapy and WM. However, the conclusion that CHM was superior to WM cannot be drawn due to the inconsistent results. Conclusion: Despite that CHM has the potential benefit and safety in the adjuvant treatment of psoriasis, the conclusion should be treated with caution because of the generally low quality of methodology and evidence. In the future, high-quality randomized controlled trials (RCTs) should be carried out, and the quality of relevant SRs should also be improved to promote their clinical application.
Collapse
Affiliation(s)
- Jie Zhang
- Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.,Chengdu University of Traditional Chinese Medicine, Chengdu, China
| | - Qianying Yu
- Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China
| | - Li Peng
- Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.,Chengdu University of Traditional Chinese Medicine, Chengdu, China
| | - Yuesi Qin
- Chengdu Integrated TCM and Western Medicine Hospital, Chengdu, China
| | - Mingyi Jing
- Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.,Chengdu University of Traditional Chinese Medicine, Chengdu, China
| | - Dan Huang
- Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.,Chengdu University of Traditional Chinese Medicine, Chengdu, China
| | - Jing Guo
- Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China
| | - Min Xiao
- Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China
| | - Mingling Chen
- Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China
| |
Collapse
|